We recently released a list According to analysts, 11 Best Decline Stocks. In this article, we will look at Thermo Fisher Scientific Inc. (NYSE:TMO) with other best downward stocks representing where to buy.
The Bulls have been in control over the past two years, and each callback has pushed the U.S. market to new heights. When AI becomes a key investment theme, especially in the technology sector, major index rallies will be held to record highs. Stocks are also gathering in the expectation that the U.S. Federal Reserve will lower inflationary pressures significantly ease interest rates. The climax gatherings brought valuations beyond historical norms.
In the United States, changes in management and policy in the United States will always be a catalyst for investors to exit risk bets in premium valuations. Donald Trump took over, launched a trade war on allies and imposed strict tariffs on imports to the United States, which was the latest headwind, lowering our stock market.
The S&P 500 has fallen by about 6%, while the technology-heavy Nasdaq has fallen by about 8%. The pullback is growing concern that the Trump-induced tariff war could put the global economy in recession. Similarly, as inflationary pressures show higher signs, the U.S. Federal Reserve is increasingly worried about avoiding lowering interest rates.
Therefore, the U.S. stock market remains on the edge, with stocks exposed to the tariff war, withdrawing at double-digit percentage points. President Trump's tariffs and policy uncertainty will certainly increase market volatility, just like his first term.
According to the Federal Reserve Bank of New York, Trump announced tariffs on Chinese imports in 2018 and 2019, resulting in poor performance in stocks. Fast forward, we see similar performance duplications for 2025, but at a larger scale.
However, the decline in the stock market will provide unique investment opportunities for investors with high risk tolerance. As prices fall, there are more and more opportunities to invest in stock trading at high discount prices.
Richard Smith, CEO of Investment Tool Risk Smith, said: “Buy dip sauces depends on your schedule. If you turn in the market and go back to new highs, you may be disappointed.”
Although it is not clear whether the stock sell-off will be released in the coming weeks, there are very safe, historically worthy of mention, stocks worth mentioning. According to Warren Buffett's strategy of seeking opportunities when having a blood bath, the best stocks in a shaky market are always those with a rare combination of quality and healthy growth potential.
According to analysts, to curate a list of 11 best stocks, we used the Finviz stock filter. We define down stocks as those within 0% to 10% of their 52-week lows. Using Finviz Stock Filters, we obtained a list of inventory that meets our criteria. Next, we rank these stocks in ascending order based on the analyst's upward potential (as of May 2). From the fourth quarter of 2024, we also mentioned hedge fund sentiment around each stock.
At Insider Monkey, we are addicted to the stocks accumulated by hedge funds. The reason is simple: Our research shows that we can beat the market by mimicking the top stocks of the best hedge funds. Our strategy for quarterly newsletters selects 14 small and large stocks quarterly, returning 275% since May 2014, exceeding 150 percentage points (See more details here).
A workstation of a research laboratory with laboratory products and services.
52-week range: $409.85 - $627.88
Current share price: $419.89
Analysts as of May 2: 34.07%
Number of hedge fund holders: 100
Thermo Fisher Scientific Inc. (NYSE:TMO) is a diagnostic and research company that provides life science solutions, analytical tools, specialized diagnostic and laboratory products. It provides reagents, instruments and consumables for biological and medical research. Its stock has a year-to-date slide of 17%, bringing it close to a 52-week low.
According to analysts, Thermo Fisher Scientific Inc. (NYSE:TMO) remains one of the best stocks to buy in the midst of a downturn. Despite lowering its target target from $620 to $470, Argus Research analysts still rate it as "stock." The purchase stance is in the context of Thermo Fisher Scientific unveiling the enhanced technology platform and the new Cho K-1 cell series. Both promised to reduce the timetable for investigative new drugs from 13 months to nine. The new system is expected to realize a new era of biopharmaceutical development.
Additionally, Thermo Fisher Scientific Inc. (NYSE:TMO) has established a strategic partnership with Roosterbio, a leading supplier of adult human mesenchymal stem/stromal cells (HMSCs). Both are accelerating the development of new potential lifesaving cell and exosome therapies as they try to take advantage of growth opportunities to treat degenerative diseases.
Overall, TMO Ranked 9 According to analysts, on our list of the best falling stocks. Although we acknowledge the potential of TMO as an investment, our belief is that AI stocks have higher returns in a shorter time frame and offer greater hope in a shorter time frame. AI stocks have risen since the beginning of 2025, while popular AI stocks have lost about 25%. If you are looking for more promising AI stocks than TMO, but their earnings are trading at less than 5 times the price, check out our report The cheapest AI stock.
Read the next article: Buy 20 Best AI Stocks Now and According to the billionaire, there are now 30 best stocks.
Disclosure: None. This article was originally published in Internal monkey.